Search for: + Vetio Animal Health Tropichem and TetraGenx announce corporate name change to Vetio Animal Health ST. LOUIS, MO (November 1, 2018) – Tropichem is proud to announce the unification of its businesses under the new company name Vetio, effective immediately. The new name has been chosen to better reflect the company’s exclusive focus as a Contract Development and Manufacturing Organization (CDMO) for Animal Health. “The launch of our new brand marks another significant step toward the Company’s goal of becoming the leading CDMO in Animal Health,” Vetio CEO John Kane said. “Our brand promise, Actualizing Animal Health, means that we work with our customers to turn their ideas into reality. Vetio is a single-source partner for successful development, technical transfers, analytical services, and manufacturing.” The company acquired TetraGenx earlier this year. At that time, the company outlined a strategy to expand its manufacturing capabilities to meet the specific needs of Animal Health companies. In September, it announced plans to build a non-sterile liquid facility in Montreal. The company is also currently in the construction phase of a solid dose plant to produce pharmaceutical soft chews, tablets, and ingredients in its Montreal location. Both plants will begin commercial production in mid to late 2019. Home Development Technical Services Manufacturing Analytical Services About Careers Contact Français ©2021 Vetio | 2705 Dougherty Ferry Rd., Suite 202 | St. Louis, MO 63122 | Privacy Policy | Terms of Use

Search for: + Vetio Animal Health Tropichem Research Labs, LLC Acquires TetraGenx, Inc. ST. LOUIS (March 26, 2018) – Tropichem Research Labs, LLC has acquired Montreal, Quebec-based TetraGenx (TGX), a leading independent animal health contract development and manufacturing organization (CDMO). TGX employees will continue to operate from its lab facility in Montreal, Quebec. TGX (www.tetragenx.com) specializes in complex drug product formulation development, working as a subcontractor to develop innovative, over-the-counter, and nutraceutical veterinary pharma products. The Company’s services encompass four main categories, including product development (pre-formulation, formulation, and analytical development); analytical testing; manufacturing; and ancillary support services. Kevin McDonnell, President, TGX said, “We are excited to partner with the Tropichem team to expand our capabilities and provide exclusive independent drug development and contract manufacturing for the animal health industry. Tropichem is a great complement to the TGX brand and mission.” John Kane, CEO, Tropichem said, “The addition of TetraGenx to Tropichem gives us much-expanded service capabilities and reach in the animal health industry. TGX has long been known to us for their management’s commitment to excellence and quality. We’re very excited to have them become part of the team.” Home Development Technical Services Manufacturing Analytical Services About Careers Contact Français ©2021 Vetio | 2705 Dougherty Ferry Rd., Suite 202 | St. Louis, MO 63122 | Privacy Policy | Terms of Use